Pier Paolo Mattogno

Pegvisomant and Pasireotide LAR as second line therapy in acromegaly: clinical effectiveness and predictors of response

Sabrina Chiloiro, Antonella Giampietro, Federica Mirra et al. · European Journal of Endocrinology · 2020 · 52 citations

The fate of a macroporous hydroxyapatite cranioplasty four years after implantation: Macroscopical and microscopical findings in a case of recurrent atypical meningioma

Paolo Frassanito, Pasquale De Bonis, Pier Paolo Mattogno et al. · Clinical Neurology and Neurosurgery · 2012 · 34 citations

Microscopical Findings, Recurrent Atypical Meningioma, Craniofacial Surgery

Reassessing the Role of Brain Tumor Biopsy in the Era of Advanced Surgical, Molecular, and Imaging Techniques—A Single-Center Experience with Long-Term Follow-Up

Rina Di Bonaventura, Nicola Montano, Martina Giordano et al. · Journal of Personalized Medicine · 2021 · 32 citations · Full text

CSF dynamics analysis in patients with post-traumatic ventriculomegaly

Pasquale De Bonis, Annunziato Mangiola, Angelo Pompucci et al. · Clinical Neurology and Neurosurgery · 2012 · 30 citations

Traumatic Brain Injury, Heart Failure, Csf Dynamics Analysis +4

Septic complication following porous hydroxyapatite cranioplasty: prosthesis retention management

Corrado Iaccarino, Pier Paolo Mattogno, Bruno Zanotti et al. · Journal of Neurosurgical Sciences · 2018 · 26 citations · Full text

Regenerative Medicine, Revision Surgery, Ha Prosthesis +13